ALFA Finder
10:13 IST
BSE
Other Announcement
Indo US Bio-Tech Other Announcement
Indo Us Bio-Tech Ltd filed its quarterly shareholding pattern under SEBI Regulation 31(1)(b) for the quarter ended September 30, 2026.
Indo US Bio-Tech Ltd
- Share price
- ₹65.33
- Market cap
- ₹131.0 Cr
- Revenue (annual)
- ₹110.4 Cr
- Net profit (annual)
- ₹13.12 Cr
- P/E (TTM)
- 30.2×Sector 29.0×
- Promoter holding
- 68.29%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Financial Results 4Board Meeting Outcome 4Annual General Meeting 4Other Announcement 3Board Meeting Date 3Management Change 1Business Update 1Annual Report 1
Time
3 announcements with these filters
15:46 IST
BSE
Other Announcement
Indo US Bio-Tech Other Announcement
Indo Us Bio-Tech reconstituted its Audit, Nomination, and Stakeholders committees effective July 10, 2026. This follows the earlier appointment of Hemanshi Darsh Soni as Additional Director.
15:46 IST
BSE
Other Announcement
Indo US Bio-Tech Other Announcement
Indo Us Bio-Tech Limited filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report details governance compliance and historical regulatory observations.